Business

Dr Reddy#39;s to launch 20 products in US in FY20

Dr Reddy#39;s to launch 20 products in US in FY20 The company anticipates US FDA approval for generic Nuvaring in the first half of FY20, while the launch of generic Copaxone in the US may get further delayed as the company received additional queries from the drug regulator relating to the product, the management said.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts